The United Laboratories International Holdings Limited (HKG:3933)
Hong Kong · Delayed Price · Currency is HKD 9.60
+0.06 (0.63%)
Apr 28, 2026, 4:08 PM HKT
HKG:3933 Market Cap
HKG:3933 has a market cap or net worth of 18.82 billion as of April 28, 2026. Its market cap has decreased by -30.94% in one year.
Market Cap
18.82B
Enterprise Value
12.67B
Revenue
14.70B
Ranking
n/a
PE Ratio
7.75
Stock Price
9.60
Market Cap Chart
Since June 15, 2007, HKG:3933's market cap has increased from 4.33B to 18.82B, an increase of 334.48%. That is a compound annual growth rate of 8.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 18.82B | -17.69% |
| Dec 31, 2025 | 22.87B | 1.82% |
| Dec 31, 2024 | 22.46B | 76.32% |
| Dec 29, 2023 | 12.74B | 43.06% |
| Dec 30, 2022 | 8.90B | 11.62% |
| Dec 31, 2021 | 7.98B | -21.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 32.60B |
| China Medical System Holdings | 32.36B |
| Sunshine Lake Pharma | 24.18B |
| Grand Pharmaceutical Group | 22.97B |
| Fujian Haixi Pharmaceuticals | 18.70B |
| Consun Pharmaceutical Group | 13.33B |
| CanSino Biologics | 12.95B |
| Xuanzhu Biopharmaceutical | 12.86B |